Showing results (231-240 of 652) with videos related to
Sort By:
Pageof 66
Psychiatric Services (Washington, D.C.)|November 16, 2013
Geographic and clinical variation in clozapine use in the United StatesT Scott Stroup, Tobias Gerhard, Stephen Crystal, et al.Journal of Managed Care & Specialty Pharmacy|June 25, 2019
Economic Burden of Treatment-Resistant Depression on the U.S. Health Care SystemMatthew Sussman, Amy K O'sullivan, Ankit Shah, et al.Health Affairs (Project Hope)|July 7, 2026
Long-Acting Injectable Buprenorphine: Uptake Was Rapid But Uneven, 2021-24Arthur Robin Williams, Jialiang Hua, Mark Olfson, et al.Journal of the American Academy of Child and Adolescent Psychiatry|May 17, 2002
National trends in the use of psychotropic medications by childrenMark Olfson, Steven C Marcus, Myrna M Weissman, et al.The American Journal of Psychiatry|June 5, 2003
National trends in the treatment of attention deficit hyperactivity disorderMark Olfson, Marc J Gameroff, Steven C Marcus, et al.Schizophrenia Research|January 2, 2023
Means of suicide among adults with schizophrenia across the life spanNatalie Bareis, Mark Olfson, Tobias Gerhard, et al.The American Journal of Psychiatry|April 22, 2020
20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care SettingsTaeho Greg Rhee, Mark Olfson, Andrew A Nierenberg, et al.Health Affairs (Project Hope)|July 16, 2002
The most expensive medical conditions in AmericaBenjamin G Druss, Steven C Marcus, Mark Olfson, et al.Psychiatric Services (Washington, D.C.)|September 5, 2003
Antipsychotic dosage at hospital discharge and outcomes among persons with schizophreniaNancy L Sohler, Jamie Walkup, Donna McAlpine, et al.Health Services Research|March 23, 2004
Delays in initial treatment contact after first onset of a mental disorderPhilip S Wang, Patricia A Berglund, Mark Olfson, et al.Pageof 66